<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02925858</url>
  </required_header>
  <id_info>
    <org_study_id>16-289</org_study_id>
    <nct_id>NCT02925858</nct_id>
  </id_info>
  <brief_title>Effect of Ketamine on Analgesia Post-Cardiac Surgery</brief_title>
  <official_title>Pilot Study: The Effect of Intraoperative Ketamine on Analgesia Post-Cardiac Surgery and Prevention of Chronic Pain</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Jewish General Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Jewish General Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Randomized, controlled, double-blind pilot study evaluating the effect of an intraoperative
      infusion of intravenous Ketamine on the quantity of opioid consumed postoperatively in
      coronary artery bypass surgery patients receiving a median sternotomy.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a randomized, controlled, double-blind pilot study to determine the effectiveness of
      intraoperative Ketamine administration on pain after coronary artery bypass surgery. Patients
      will be randomized to receive ketamine or saline prior to incision, with a continuous
      infusion throughout surgery. Opioid dose administered in the first 48 hours will then be
      documented as the primary outcome
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">August 28, 2017</start_date>
  <completion_date type="Actual">November 27, 2018</completion_date>
  <primary_completion_date type="Actual">November 1, 2018</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Quantity of Opioids Used in the First 48 Hours Postoperatively</measure>
    <time_frame>First 48 hours after arrival to the ICU</time_frame>
    <description>Opioids used, in Dilaudid equivalents</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Quantity of Opioids Used</measure>
    <time_frame>24 hours postoperatively</time_frame>
    <description>Quantity in mg</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain Scores (Visual Analog Scale)</measure>
    <time_frame>Postoperative days 2</time_frame>
    <description>Average Pain Score as reported by the patient on a numeric scale ranging from 0 (no pain) to a maximum of 10 points (worst pain imaginable)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Postoperative Nausea and Vomiting</measure>
    <time_frame>48 hours after ICU arrival</time_frame>
    <description>Whether or not the patient suffered from nausea and vomiting after surgery which required treatment</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Intensive Care Unit Length of Stay</measure>
    <time_frame>1 day - 2 weeks</time_frame>
    <description>Number of days spent in the intensive care unit</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hospital Length of Stay</measure>
    <time_frame>5 days - 2 weeks</time_frame>
    <description>number of days spent in the hospital, starting from the day of surgery</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time to Extubation</measure>
    <time_frame>4 hours - 2 weeks</time_frame>
    <description>Number of minutes from the time of ICU arrival to extubation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Delirium</measure>
    <time_frame>ICU stay</time_frame>
    <description>Delirium as assessed by a positive CAM-ICU score during the ICU stay</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time to Mobilization</measure>
    <time_frame>During hospital stay</time_frame>
    <description>Time from ICU arrival until patient able to mobilize to chair, measured in hours</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time to Ambulation</measure>
    <time_frame>1 week postoperatively</time_frame>
    <description>Time from ICU arrival until patient able to ambulate, measured in hours</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">80</enrollment>
  <condition>Pain, Postoperative</condition>
  <arm_group>
    <arm_group_label>Intervention</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Intraoperative infusion of ketamine</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Control group receiving a saline infusion</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Normal Saline Flush, 0.9% Injectable Solution_#1</intervention_name>
    <description>Normal saline infusion mimicking infusion rate of ketamine for a given weight</description>
    <arm_group_label>Control</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ketamine Hydrochloride</intervention_name>
    <description>Ketamine IV infusion (0.5mg/kg bolus prior to incision, 0.5mg/kg/hr until the end of surgery)</description>
    <arm_group_label>Intervention</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients 18 years of age or older coming for coronary artery bypass surgery with a
             left ventricular ejection fraction over 50% and able to consent prior to surgery

        Exclusion Criteria:

          -  Minimally invasive cardiac surgery

          -  Preoperative opioid use

          -  Preoperative hepatic or renal dysfunction
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Matthew Cameron, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Jewish General Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Jewish General Hospital</name>
      <address>
        <city>Montreal</city>
        <state>Quebec</state>
        <zip>H3T1E2</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>August 2019</verification_date>
  <study_first_submitted>October 4, 2016</study_first_submitted>
  <study_first_submitted_qc>October 5, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 6, 2016</study_first_posted>
  <results_first_submitted>March 1, 2019</results_first_submitted>
  <results_first_submitted_qc>August 6, 2019</results_first_submitted_qc>
  <results_first_posted type="Actual">September 6, 2019</results_first_posted>
  <last_update_submitted>August 6, 2019</last_update_submitted>
  <last_update_submitted_qc>August 6, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">September 6, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Jewish General Hospital</investigator_affiliation>
    <investigator_full_name>Matthew Cameron</investigator_full_name>
    <investigator_title>Assistant Professor</investigator_title>
  </responsible_party>
  <keyword>Ketamine</keyword>
  <keyword>Cardiac surgery</keyword>
  <keyword>Pain</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pain, Postoperative</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ketamine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>Will provide all uncoded data</ipd_description>
    <ipd_info_type>Study Protocol</ipd_info_type>
    <ipd_info_type>Statistical Analysis Plan (SAP)</ipd_info_type>
    <ipd_info_type>Informed Consent Form (ICF)</ipd_info_type>
    <ipd_info_type>Analytic Code</ipd_info_type>
    <ipd_time_frame>Upon request, starting 6 months after publication</ipd_time_frame>
    <ipd_access_criteria>For planned meta-analyses</ipd_access_criteria>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>August 23, 2017</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/58/NCT02925858/Prot_SAP_000.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Intervention</title>
          <description>Intraoperative infusion of ketamine
Ketamine Hydrochloride: Ketamine IV infusion (0.5mg/kg bolus prior to incision, 0.5mg/kg/hr until the end of surgery)</description>
        </group>
        <group group_id="P2">
          <title>Control</title>
          <description>Control group receiving a saline infusion
Normal Saline Flush, 0.9% Injectable Solution_#1: Normal saline infusion mimicking infusion rate of ketamine for a given weight</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="42"/>
                <participants group_id="P2" count="38"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="42"/>
                <participants group_id="P2" count="38"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Ketamine</title>
          <description>Bolus 0.5mg/kg, Infusion 0.5mg/kg/hr</description>
        </group>
        <group group_id="B2">
          <title>Placebo</title>
          <description>Normal Saline 0.025cc/kg bolus, 0.025cc/kg/hr</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="42"/>
            <count group_id="B2" value="38"/>
            <count group_id="B3" value="80"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="42"/>
                    <count group_id="B2" value="38"/>
                    <count group_id="B3" value="80"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="65.9" spread="9.6"/>
                    <measurement group_id="B2" value="67.1" spread="8.6"/>
                    <measurement group_id="B3" value="66.5" spread="9.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="42"/>
                    <count group_id="B2" value="38"/>
                    <count group_id="B3" value="80"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="4"/>
                    <measurement group_id="B2" value="5"/>
                    <measurement group_id="B3" value="9"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="38"/>
                    <measurement group_id="B2" value="33"/>
                    <measurement group_id="B3" value="71"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race and Ethnicity Not Collected</title>
          <population>Race and Ethnicity were not collected from any participant.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="0"/>
                    <count group_id="B2" value="0"/>
                    <count group_id="B3" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>Canada</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="42"/>
                    <count group_id="B2" value="38"/>
                    <count group_id="B3" value="80"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="42"/>
                    <measurement group_id="B2" value="38"/>
                    <measurement group_id="B3" value="80"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Body Mass Index (kg/m^2)</title>
          <units>kg/m^2</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="42"/>
                    <count group_id="B2" value="38"/>
                    <count group_id="B3" value="80"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="29.0" spread="4.2"/>
                    <measurement group_id="B2" value="28.0" spread="4.0"/>
                    <measurement group_id="B3" value="28.5" spread="4.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Cardiopulmonary Bypass time (mins)</title>
          <units>mins</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="42"/>
                    <count group_id="B2" value="38"/>
                    <count group_id="B3" value="80"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="105.4" spread="33.7"/>
                    <measurement group_id="B2" value="108.2" spread="29.6"/>
                    <measurement group_id="B3" value="106.7" spread="31.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Cross Clamp Time (mins)</title>
          <units>minutes</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="42"/>
                    <count group_id="B2" value="38"/>
                    <count group_id="B3" value="80"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="83.6" spread="33.4"/>
                    <measurement group_id="B2" value="82.7" spread="25.6"/>
                    <measurement group_id="B3" value="83.6" spread="33.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Intraoperative Sufentanil per kg</title>
          <units>mcg/kg</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="42"/>
                    <count group_id="B2" value="38"/>
                    <count group_id="B3" value="80"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="2.17" spread="1.11"/>
                    <measurement group_id="B2" value="1.96" spread="0.86"/>
                    <measurement group_id="B3" value="2.07" spread="1.07"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Quantity of Opioids Used in the First 48 Hours Postoperatively</title>
        <description>Opioids used, in Dilaudid equivalents</description>
        <time_frame>First 48 hours after arrival to the ICU</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Ketamine</title>
            <description>Intraoperative infusion of ketamine
Ketamine Hydrochloride: Ketamine IV infusion (0.5mg/kg bolus prior to incision, 0.5mg/kg/hr until the end of surgery)</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>Control group receiving a saline infusion
Normal Saline Flush, 0.9% Injectable Solution_#1: Normal saline infusion mimicking infusion rate of ketamine for a given weight</description>
          </group>
        </group_list>
        <measure>
          <title>Quantity of Opioids Used in the First 48 Hours Postoperatively</title>
          <description>Opioids used, in Dilaudid equivalents</description>
          <units>mg of Dilaudid</units>
          <param>Mean</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="42"/>
                <count group_id="O2" value="38"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="10.71" lower_limit="9.41" upper_limit="12.02"/>
                    <measurement group_id="O2" value="11.14" lower_limit="9.68" upper_limit="12.61"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Quantity of Opioids Used</title>
        <description>Quantity in mg</description>
        <time_frame>24 hours postoperatively</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Ketamine</title>
            <description>Intraoperative infusion of ketamine
Ketamine Hydrochloride: Ketamine IV infusion (0.5mg/kg bolus prior to incision, 0.5mg/kg/hr until the end of surgery)</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>Control group receiving a saline infusion
Normal Saline Flush, 0.9% Injectable Solution_#1: Normal saline infusion mimicking infusion rate of ketamine for a given weight</description>
          </group>
        </group_list>
        <measure>
          <title>Quantity of Opioids Used</title>
          <description>Quantity in mg</description>
          <units>mg of Dilaudid</units>
          <param>Mean</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="42"/>
                <count group_id="O2" value="38"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6.5" lower_limit="5.75" upper_limit="7.24"/>
                    <measurement group_id="O2" value="6.7" lower_limit="5.94" upper_limit="7.45"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Pain Scores (Visual Analog Scale)</title>
        <description>Average Pain Score as reported by the patient on a numeric scale ranging from 0 (no pain) to a maximum of 10 points (worst pain imaginable)</description>
        <time_frame>Postoperative days 2</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Ketamine</title>
            <description>Intraoperative infusion of ketamine
Ketamine Hydrochloride: Ketamine IV infusion (0.5mg/kg bolus prior to incision, 0.5mg/kg/hr until the end of surgery)</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>Control group receiving a saline infusion
Normal Saline Flush, 0.9% Injectable Solution_#1: Normal saline infusion mimicking infusion rate of ketamine for a given weight</description>
          </group>
        </group_list>
        <measure>
          <title>Pain Scores (Visual Analog Scale)</title>
          <description>Average Pain Score as reported by the patient on a numeric scale ranging from 0 (no pain) to a maximum of 10 points (worst pain imaginable)</description>
          <units>score on a scale</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="42"/>
                <count group_id="O2" value="38"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2" lower_limit="0" upper_limit="4.25"/>
                    <measurement group_id="O2" value="2" lower_limit="0" upper_limit="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Postoperative Nausea and Vomiting</title>
        <description>Whether or not the patient suffered from nausea and vomiting after surgery which required treatment</description>
        <time_frame>48 hours after ICU arrival</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Ketamine</title>
            <description>Intraoperative infusion of ketamine
Ketamine Hydrochloride: Ketamine IV infusion (0.5mg/kg bolus prior to incision, 0.5mg/kg/hr until the end of surgery)</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>Control group receiving a saline infusion
Normal Saline Flush, 0.9% Injectable Solution_#1: Normal saline infusion mimicking infusion rate of ketamine for a given weight</description>
          </group>
        </group_list>
        <measure>
          <title>Postoperative Nausea and Vomiting</title>
          <description>Whether or not the patient suffered from nausea and vomiting after surgery which required treatment</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="42"/>
                <count group_id="O2" value="38"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3"/>
                    <measurement group_id="O2" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Intensive Care Unit Length of Stay</title>
        <description>Number of days spent in the intensive care unit</description>
        <time_frame>1 day - 2 weeks</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Ketamine</title>
            <description>Intraoperative infusion of ketamine
Ketamine Hydrochloride: Ketamine IV infusion (0.5mg/kg bolus prior to incision, 0.5mg/kg/hr until the end of surgery)</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>Control group receiving a saline infusion
Normal Saline Flush, 0.9% Injectable Solution_#1: Normal saline infusion mimicking infusion rate of ketamine for a given weight</description>
          </group>
        </group_list>
        <measure>
          <title>Intensive Care Unit Length of Stay</title>
          <description>Number of days spent in the intensive care unit</description>
          <units>days</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="42"/>
                <count group_id="O2" value="38"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1" lower_limit="0" upper_limit="3"/>
                    <measurement group_id="O2" value="2" lower_limit="0" upper_limit="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Hospital Length of Stay</title>
        <description>number of days spent in the hospital, starting from the day of surgery</description>
        <time_frame>5 days - 2 weeks</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Ketamine</title>
            <description>Intraoperative infusion of ketamine
Ketamine Hydrochloride: Ketamine IV infusion (0.5mg/kg bolus prior to incision, 0.5mg/kg/hr until the end of surgery)</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>Control group receiving a saline infusion
Normal Saline Flush, 0.9% Injectable Solution_#1: Normal saline infusion mimicking infusion rate of ketamine for a given weight</description>
          </group>
        </group_list>
        <measure>
          <title>Hospital Length of Stay</title>
          <description>number of days spent in the hospital, starting from the day of surgery</description>
          <units>days</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="42"/>
                <count group_id="O2" value="38"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8" lower_limit="3" upper_limit="13"/>
                    <measurement group_id="O2" value="7" lower_limit="2" upper_limit="12"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Time to Extubation</title>
        <description>Number of minutes from the time of ICU arrival to extubation</description>
        <time_frame>4 hours - 2 weeks</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Ketamine</title>
            <description>Intraoperative infusion of ketamine
Ketamine Hydrochloride: Ketamine IV infusion (0.5mg/kg bolus prior to incision, 0.5mg/kg/hr until the end of surgery)</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>Control group receiving a saline infusion
Normal Saline Flush, 0.9% Injectable Solution_#1: Normal saline infusion mimicking infusion rate of ketamine for a given weight</description>
          </group>
        </group_list>
        <measure>
          <title>Time to Extubation</title>
          <description>Number of minutes from the time of ICU arrival to extubation</description>
          <units>minutes</units>
          <param>Mean</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="42"/>
                <count group_id="O2" value="38"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="539" lower_limit="397" upper_limit="682"/>
                    <measurement group_id="O2" value="494" lower_limit="383" upper_limit="605"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Delirium</title>
        <description>Delirium as assessed by a positive CAM-ICU score during the ICU stay</description>
        <time_frame>ICU stay</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Ketamine</title>
            <description>Intraoperative infusion of ketamine
Ketamine Hydrochloride: Ketamine IV infusion (0.5mg/kg bolus prior to incision, 0.5mg/kg/hr until the end of surgery)</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>Control group receiving a saline infusion
Normal Saline Flush, 0.9% Injectable Solution_#1: Normal saline infusion mimicking infusion rate of ketamine for a given weight</description>
          </group>
        </group_list>
        <measure>
          <title>Delirium</title>
          <description>Delirium as assessed by a positive CAM-ICU score during the ICU stay</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="42"/>
                <count group_id="O2" value="38"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="11"/>
                    <measurement group_id="O2" value="7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Time to Mobilization</title>
        <description>Time from ICU arrival until patient able to mobilize to chair, measured in hours</description>
        <time_frame>During hospital stay</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Ketamine</title>
            <description>Intraoperative infusion of ketamine
Ketamine Hydrochloride: Ketamine IV infusion (0.5mg/kg bolus prior to incision, 0.5mg/kg/hr until the end of surgery)</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>Control group receiving a saline infusion
Normal Saline Flush, 0.9% Injectable Solution_#1: Normal saline infusion mimicking infusion rate of ketamine for a given weight</description>
          </group>
        </group_list>
        <measure>
          <title>Time to Mobilization</title>
          <description>Time from ICU arrival until patient able to mobilize to chair, measured in hours</description>
          <units>hours</units>
          <param>Mean</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="42"/>
                <count group_id="O2" value="36"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="32" lower_limit="26" upper_limit="40"/>
                    <measurement group_id="O2" value="23" lower_limit="20" upper_limit="27"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Time to Ambulation</title>
        <description>Time from ICU arrival until patient able to ambulate, measured in hours</description>
        <time_frame>1 week postoperatively</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Ketamine</title>
            <description>Intraoperative infusion of ketamine
Ketamine Hydrochloride: Ketamine IV infusion (0.5mg/kg bolus prior to incision, 0.5mg/kg/hr until the end of surgery)</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>Control group receiving a saline infusion
Normal Saline Flush, 0.9% Injectable Solution_#1: Normal saline infusion mimicking infusion rate of ketamine for a given weight</description>
          </group>
        </group_list>
        <measure>
          <title>Time to Ambulation</title>
          <description>Time from ICU arrival until patient able to ambulate, measured in hours</description>
          <units>hours</units>
          <param>Mean</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="42"/>
                <count group_id="O2" value="36"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="63" lower_limit="54" upper_limit="76"/>
                    <measurement group_id="O2" value="56" lower_limit="46" upper_limit="64"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>1 year, 6 months</time_frame>
      <desc>No noted adverse events</desc>
      <group_list>
        <group group_id="E1">
          <title>Ketamine</title>
          <description>Intraoperative infusion of ketamine
Ketamine Hydrochloride: Ketamine IV infusion (0.5mg/kg bolus prior to incision, 0.5mg/kg/hr until the end of surgery)</description>
        </group>
        <group group_id="E2">
          <title>Placebo</title>
          <description>Control group receiving a saline infusion
Normal Saline Flush, 0.9% Injectable Solution_#1: Normal saline infusion mimicking infusion rate of ketamine for a given weight</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="38"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="38"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="38"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Dr Matthew Cameron</name_or_title>
      <organization>Jewish General Hospital</organization>
      <phone>514-340-8222 ext 25701</phone>
      <email>matthew.cameron@mcgill.ca</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

